StockDrifts LogoStockDrifts

Daito Pharmaceutical Co.,Ltd. 4577

Company
ダイト株式会社Daito Pharmaceutical Co.,Ltd.
Investors
9
Buys
15
Total Value
¥2.9B ($18.8M)
Avg Return
+2.26%
Last Filing
2026-02-04

Daito Pharmaceutical Co.,Ltd. (4577) has 15 disclosed large-shareholding filings and 15 disclosed disposals on record, filed by 9 distinct investors. Together those filings cover ¥2.9B ($18.8M) in reported transaction value. The earliest filing StockDrifts holds for Daito Pharmaceutical Co.,Ltd. is dated 2021-04-22; the most recent is 2026-02-04. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is +2.26%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2026-02-04SELLMarket Buy
マサチューセッツ・ファイナンシャル・サービセズ・カンパニー(Massachusetts Financial Services Company)
Massachusetts Financial Services Company
passive1.2M¥1,354+0.3%¥465M ($3.0M)
2025-08-12BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive3.4M¥1,243+8.6%¥430M ($2.8M)
2025-08-12BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive3.4M¥1,243+8.6%¥430M ($2.8M)
2025-06-06BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive1.5M¥1,020+32.4%¥1.6B ($10.1M)
2024-08-22BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive1.5M¥1,199.5+12.6%¥188M ($1.2M)
2024-06-26BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive1.4M¥1,137.5+18.7%¥200M ($1.3M)
2024-05-07BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive1.2M¥1,271+6.2%¥223M ($1.4M)
2024-03-25BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive1.1M¥1,158+16.6%¥211M ($1.4M)
2024-03-25BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive1.1M¥1,158+16.6%¥200M ($1.3M)
2024-01-31BUYMarket Buy
カナメ・キャピタル・エルピー(Kaname Capital,L.P.)
Kaname Capital, L.P.
passive893.1K¥987.5+36.7%¥882M ($5.7M)
2024-01-11SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other672.7K¥972-38.9%¥160M ($1.0M)
2023-12-07SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other838.1K¥958.5-40.9%¥486M ($3.1M)
2023-11-08SELLunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other1.3M¥965.5-39.8%¥228M ($1.5M)
2023-07-12SELLunknown
ハイクレア・インターナショナル・インベスターズ・エルエルピー(Highclere International Investors LLP)
Highclere International Investors LLP
other571.7K¥970-39.2%¥147M ($947K)
2023-06-06SELLunknown
日興アセットマネジメント株式会社
Nikko Asset Management Co.,Ltd.
other195.2K¥1,066.82-26.5%¥9M ($60K)
2023-06-06SELLunknown
三井住友トラスト・アセットマネジメント株式会社
Sumitomo Mitsui Trust Asset Management Co.,Ltd.
other464.4K¥1,066.82-26.5%¥152M ($982K)
2022-08-04SELLunknown
大和証券株式会社
Daiwa Securities Co.Ltd.
other700¥1,163.18-16.1%¥7M ($47K)
2022-08-04BUYunknown
大和アセットマネジメント株式会社
Daiwa Asset Management Co.Ltd.
other224.0K¥1,163.18+16.1%¥261M ($1.7M)
2022-07-06SELLunknown
大和証券株式会社
Daiwa Securities Co.Ltd.
other646.9K¥1,263.64-6.8%¥205M ($1.3M)
2022-07-06BUYunknown
大和アセットマネジメント株式会社
Daiwa Asset Management Co.Ltd.
other222.3K¥1,263.64+6.8%¥281M ($1.8M)
2022-05-10SELLunknown
大和証券株式会社
Daiwa Securities Co.Ltd.
other816.6K¥1,211.36-11.4%¥177M ($1.1M)
2022-05-10SELLunknown
大和アセットマネジメント株式会社
Daiwa Asset Management Co.Ltd.
other220.1K¥1,211.36-11.4%¥2M ($11K)
2022-03-23BUYMarket Buy
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other1.4M¥1,298.64+4.0%¥223M ($1.4M)
2022-03-22BUYMarket Buy
マサチューセッツ・ファイナンシャル・サービセズ・カンパニー(Massachusetts Financial Services Company)
Massachusetts Financial Services Company
passive709.6K¥1,264.54+6.8%¥897M ($5.8M)
2022-03-04SELLunknown
大和アセットマネジメント株式会社
Daiwa Asset Management Co.Ltd.
other218.5K¥1,354.54+0.3%¥4M ($25K)
2022-03-04SELLunknown
大和証券株式会社
Daiwa Securities Co.Ltd.
other971.7K¥1,354.54+0.3%¥225M ($1.4M)
2021-12-20BUYunknown
大和アセットマネジメント株式会社
Daiwa Asset Management Co.Ltd.
other217.9K¥1,330.45+1.5%¥290M ($1.9M)
2021-12-20SELLunknown
大和証券株式会社
Daiwa Securities Co.Ltd.
other1.1M¥1,330.45-1.5%¥186M ($1.2M)
2021-12-07BUYMarket Buy
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other1.2M¥1,363.18-1.0%¥298M ($1.9M)
2021-10-21SELLMarket Buy
三井住友DSアセットマネジメント株式会社
Sumitomo Mitsui DS Asset Management Company, Limited
passive540.3K¥1,479.54+8.8%¥219M ($1.4M)
2021-10-05BUYunknown
大和アセットマネジメント株式会社
Daiwa Asset Management Co.Ltd.
other217.2K¥1,431.82-5.7%¥311M ($2.0M)
2021-10-05BUYunknown
大和証券株式会社
Daiwa Securities Co.Ltd.
other1.3M¥1,431.82-5.7%¥1.9B ($12.0M)
2021-09-07BUYMarket Buy
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other983.0K¥1,695.45-20.4%¥237M ($1.5M)
2021-08-03BUYunknown
ハイクレア・インターナショナル・インベスターズ・エルエルピー(Highclere International Investors LLP)
Highclere International Investors LLP
other689.3K¥1,525-11.5%¥1.1B ($6.8M)
2021-08-03BUYunknown
ハイクレア・インターナショナル・インベスターズ・エルエルピー(Highclere International Investors LLP)
Highclere International Investors LLP
other689.3K¥1,525-11.5%¥1.1B ($6.8M)
2021-07-07BUYMarket Buy
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other843.6K¥1,577.27-14.4%¥236M ($1.5M)
2021-04-22BUYunknown
エフエムアール エルエルシー(FMR LLC)
FMR LLC
other694.7K¥1,636.36-17.5%¥1.1B ($7.3M)

Frequently asked questions

Who has been buying Daito Pharmaceutical Co.,Ltd. stock?
9 distinct investors have filed 15 disclosed large-shareholding filings in Daito Pharmaceutical Co.,Ltd. (4577), most recently on 2026-02-04. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Daito Pharmaceutical Co.,Ltd. have?
Daito Pharmaceutical Co.,Ltd. has 15 buy-side and 15 sell-side disclosures on record, covering ¥2.9B ($18.8M) in total reported value, spanning 2021-04-22 to 2026-02-04.
Where does StockDrifts get Daito Pharmaceutical Co.,Ltd. insider data?
From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for Daito Pharmaceutical Co.,Ltd.. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.